Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2012. Revenues for the quarter ended December 31, 2012, were $1,475,000, a 6% increase from revenues of $1,390,000 for the same quarter of the prior year. The company had a net loss of $144,000 or $0.01 per share for the current quarter, compared to a loss of $285,000 or $0.02 per share for the same quarter of the prior year.